Phase 1 Estrogen Receptor Positive Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

PRE-I-SPY Phase I/Ib Oncology Platform Program

Triple-Negative Breast CancerMetastatic Breast CancerHER2-low Breast Cancer+18 more

QuantumLeap Healthcare Collaborative124 enrolled7 locationsNCT05868226

Completed

Phase 1

A Phase I, Randomised, Double-Blinded, Placebo Controlled, Safety and Pharmacokinetic Study of (Z)-Endoxifen in Healthy Female Volunteers

Estrogen Receptor Positive (ER+) breast cancer

Atossa Genetics AUS Pty Ltd24 enrolled1 locationACTRN12619000961145